ALVOTECH |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.95 USD | +0.29% |
|
+2.57% | +21.52% |
| May. 24 | Barclays Adjusts Price Target on Alvotech to $22 From $20, Maintains Overweight Rating | MT |
| May. 22 | Transcript : Alvotech, Q1 2024 Earnings Call, May 22, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 3.9B | - | |||||
| 59.34B | - | |||||
| 40.24B | ||||||
| 39.88B | ||||||
| 28.55B | ||||||
| 27.26B |
- Stock Market
- Equities
- ALVO Stock
- Charts Alvotech
- Sector Chart
